Paper39201329
Fibrosis and Hepatocarcinogenesis: Role of Gene-Environment Interactions in Liver Disease Progression.
Banerjee A and 1 other. Int J Mol Sci, 2024. Cited by 22 papers, by iCite.
Cite this record
ConductScience Library. Fibrosis and Hepatocarcinogenesis: Role of Gene-Environment Interactions in Liver Disease Progression. Papers, record 39201329. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39201329
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Fibrosis and Hepatocarcinogenesis: Role of Gene-Environment Interactions in Liver Disease Progression.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Liver Neoplasms | Major topic |
| Liver Cirrhosis | Major topic |
| Disease Progression | Major topic |
| Gene-Environment Interaction | Major topic |
| Humans | |
| Animals | |
| Hepatic Stellate Cells | |
| Carcinoma, Hepatocellular | |
| Carcinogenesis | |
| Extracellular Matrix | |
| Liver |
Source PubMed
References205
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11554450 | SAG/ROC/Rbx/Hrt, a zinc RING finger gene family: molecular cloning, biochemical properties, and biological functions. | Antioxid Redox Signal | 2001 | https://conductscience.org/library/papers/11554450 | PubMed |
| 2 | 16842882 | Liver fibrosis induced by hepatic overexpression of PDGF-B in transgenic mice. | J Hepatol | 2006 | https://conductscience.org/library/papers/16842882 | PubMed |
| 3 | 35397207 | Progressive liver, kidney, and heart degeneration in children and adults affected by TULP3 mutations. | Am J Hum Genet | 2022 | https://conductscience.org/library/papers/35397207 | PubMed |
| 4 | 29970958 | Salidroside ameliorates autophagy and activation of hepatic stellate cells in mice via NF-κB and TGF-β1/Smad3 pathways. | Drug Des Devel Ther | 2018 | https://conductscience.org/library/papers/29970958 | PubMed |
| 5 | 22974708 | Notch signaling is activated in human hepatocellular carcinoma and induces tumor formation in mice. | Gastroenterology | 2012 | https://conductscience.org/library/papers/22974708 | PubMed |
| 6 | 25695599 | Mer receptor tyrosine kinase mediates both tethering and phagocytosis of apoptotic cells. | Cell Death Dis | 2015 | https://conductscience.org/library/papers/25695599 | PubMed |
| 7 | 24265236 | Hepatic stellate cells and liver fibrosis. | Compr Physiol | 2013 | https://conductscience.org/library/papers/24265236 | PubMed |
| 8 | 28741298 | Interferon lambda 4 rs368234815 TT>δG variant is associated with liver damage in patients with nonalcoholic fatty liver disease. | Hepatology | 2017 | https://conductscience.org/library/papers/28741298 | PubMed |
| 9 | 28875549 | The contribution of toll-like receptor signaling to the development of liver fibrosis and cancer in hepatocyte-specific TAK1-deleted mice. | Int J Cancer | 2018 | https://conductscience.org/library/papers/28875549 | PubMed |
| 10 | 22173161 | Intestinal decontamination inhibits TLR4 dependent fibronectin-mediated cross-talk between stellate cells and endothelial cells in liver fibrosis in mice. | J Hepatol | 2012 | https://conductscience.org/library/papers/22173161 | PubMed |
| 11 | 18852116 | Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling. | Mol Cancer Ther | 2008 | https://conductscience.org/library/papers/18852116 | PubMed |
| 12 | 31195692 | TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31195692 | PubMed |
| 13 | 24983318 | TAK1-mediated autophagy and fatty acid oxidation prevent hepatosteatosis and tumorigenesis. | J Clin Invest | 2014 | https://conductscience.org/library/papers/24983318 | PubMed |
| 14 | 30723271 | A variant in the MICA gene is associated with liver fibrosis progression in chronic hepatitis C through TGF-β1 dependent mechanisms. | Sci Rep | 2019 | https://conductscience.org/library/papers/30723271 | PubMed |
| 15 | 37484431 | Exploring the potential of treating chronic liver disease targeting the PI3K/Akt pathway and polarization mechanism of macrophages. | Heliyon | 2023 | https://conductscience.org/library/papers/37484431 | PubMed |
| 16 | 26676815 | Genome-Wide Association Studies and Hepatitis C: Harvesting the Benefits of the Genomic Revolution. | Semin Liver Dis | 2015 | https://conductscience.org/library/papers/26676815 | PubMed |
| 17 | 22885334 | Hedgehog controls hepatic stellate cell fate by regulating metabolism. | Gastroenterology | 2012 | https://conductscience.org/library/papers/22885334 | PubMed |
| 18 | 29950858 | Multiple biological functions of transcription factor 21 in the development of various cancers. | Onco Targets Ther | 2018 | https://conductscience.org/library/papers/29950858 | PubMed |
| 19 | 27307212 | IFNL3/4 genotype is associated with altered immune cell populations in peripheral blood in chronic hepatitis C infection. | Genes Immun | 2016 | https://conductscience.org/library/papers/27307212 | PubMed |
| 20 | 29221811 | Matrix metalloproteinase functions in hepatic injury and fibrosis. | Matrix Biol | 2018 | https://conductscience.org/library/papers/29221811 | PubMed |
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42256886 | Engineered protein nanoclusters reduce liver fibrosis and hepatocellular carcinoma in mice models. | Bioact Mater | 2026 | https://conductscience.org/library/papers/42256886 | PubMed |
| 42174523 | Potentially functional variants of CYP2A6 and ABHD12 in the arachidonic acid metabolism pathway genes predict the survival of HBV-related hepatocellular carcinoma patients. | BMC Cancer | 2026 | https://conductscience.org/library/papers/42174523 | PubMed |
| 42099598 | Inflammation in hepatocellular carcinoma progression: a "Single Wick, dual interwoven strands" regulatory framework. | Front Immunol | 2026 | https://conductscience.org/library/papers/42099598 | PubMed |
| 41746109 | Therapeutic Strategies for Hepatocellular Carcinoma: Current Advances and Future Perspectives. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/41746109 | PubMed |
| 41660123 | Nanozyme for precision treatment of hepatocellular carcinoma. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/41660123 | PubMed |
| 41425491 | Dihydroartemisinin: A Promising Therapeutic Agent Against the Hepatitis-to-Hepatocellular Carcinoma Cascade. | Drug Des Devel Ther | 2025 | https://conductscience.org/library/papers/41425491 | PubMed |
| 41419501 | Vitisin A inhibits liver fibrosis by promoting Nrf2/HO-1 pathway and inhibiting Cuproptosis. | Sci Rep | 2025 | https://conductscience.org/library/papers/41419501 | PubMed |
| 41394902 | Prognostic Significance of Preoperative Inflammatory and Liver Fibrosis Markers in Hepatocellular Carcinoma. | J Inflamm Res | 2025 | https://conductscience.org/library/papers/41394902 | PubMed |
| 41097053 | Effects of the Polar Fraction of Lophocereus schottii on Gene Expression and Hepatocyte Proliferation in a Wistar Rat Model of Hepatocellular Carcinoma. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41097053 | PubMed |
| 41011192 | Present and Future Perspectives in the Treatment of Liver Fibrosis. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/41011192 | PubMed |
| 40730679 | Pantothenic acid ameliorates hepatic fibrosis by targeting IGFBP6 to regulate the TGF-β/SMADs pathway. | Commun Biol | 2025 | https://conductscience.org/library/papers/40730679 | PubMed |
| 40407830 | Clinical and Endoscopic-Histological Features of Multifocal and Corpus-Restricted Atrophic Gastritis Patients With Non-Cardia Gastric Cancer or Dysplasia: A Multicenter, Cross-Sectional Study. | Clin Transl Gastroenterol | 2025 | https://conductscience.org/library/papers/40407830 | PubMed |
| 39957024 | The burden of cancer in metabolic dysfunction-associated steatotic liver disease. | Rom J Morphol Embryol | 2024 | https://conductscience.org/library/papers/39957024 | PubMed |
| 39810142 | Correlation of sarcopenia with progression of liver fibrosis in patients with metabolic dysfunction-associated steatotic liver disease: a study from two cohorts in China and the United States. | Nutr J | 2025 | https://conductscience.org/library/papers/39810142 | PubMed |
| 39373865 | Long noncoding RNA MEG3: an active player in fibrosis. | Pharmacol Rep | 2025 | https://conductscience.org/library/papers/39373865 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39201329
GET https://conductscience.org/api/papers/v1/39201329/references?page=2